Using the cBioPortal, we validated the co-occurrence or mutual exclusivity of gene mutations with BRCA2 genetic alterations in prostate cancer public datasets (6875 patients or 7151 samples from 22 studies). Here, BRCA2 is linked to Familial prostate cancer.